Detection of alpha-1 antitrypsin deficiency: the past, present and future

BACKGROUND: Most patients with alpha-1 antitrypsin deficiency remain undiagnosed and therefore do not benefit from current therapies or become eligible for research studies of new treatments under development. Improving the detection rate for AATD is therefore a high priority for the Alpha-1 Foundat...

Descripción completa

Detalles Bibliográficos
Autores principales: Brantly, Mark, Campos, Michael, Davis, Angela M., D’Armiento, Jeanine, Goodman, Kenneth, Hanna, Kathi, O’Day, Miriam, Queenan, John, Sandhaus, Robert, Stoller, James, Strange, Charlie, Teckman, Jeffrey, Wanner, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168939/
https://www.ncbi.nlm.nih.gov/pubmed/32306990
http://dx.doi.org/10.1186/s13023-020-01352-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168939/
https://www.ncbi.nlm.nih.gov/pubmed/32306990
http://dx.doi.org/10.1186/s13023-020-01352-5

Ejemplares similares